Share option award
IXICO plc has issued 400,000 share options to advisors, with an exercise price of £0.01, following shareholder approval of a non-employee sub-plan. These options have vesting criteria tied to a two-year service period, aligning advisor compensation with their contracted services.
Select text to share a quote on X · sign in to keep highlights & notes in your IXI notes
27 July 2026: IXICO plc (AIM: IXI), IXICO, a global leader in neuroscience imaging and biomarker analytics, using its AI-driven platform to help advance drug development and diagnostics in neurological disorders, today announced that the Company has issued a total of 400,000 share options.
These options are awarded to advisors of the Company. The award follows the approval of a non-employee sub-plan to the IXICO share option plan by shareholders at the general meeting of the Company on 16 April 2026.
These options have vesting criteria aligned with the services to which the advisors are contracted over a two-year period. The options have an exercise price of £0.01.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.